Randomized, double-blind, placebo-controlled phase 3 study of ibrutinib plus rituximab in patients with previously untreated marginal zone lymphoma (MZL) Meeting Abstract
| Authors: | Noy, A.; Hughes, S.; Biggar, E.; Bogdan, M. |
| Abstract Title: | Randomized, double-blind, placebo-controlled phase 3 study of ibrutinib plus rituximab in patients with previously untreated marginal zone lymphoma (MZL) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120307023 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS7576 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS7576 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
